MedTrace Logo

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07254702 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-02-11

No results posted yet for this study

Summary

This is an observational study with primary data collection, which will combine a prospective safety cohort study and an SCRI study.

Conditions

  • Chikungunya Virus Infection

Interventions

BIOLOGICAL

Live-attenuated CHIKV vaccine VLA1553

Non-interventional study: VLA1553 is used in the pilot vaccination strategy which will start along with this observational study.

Sponsors & Collaborators

  • Fundação Butantan

    collaborator UNKNOWN

  • Coalition for Epidemic Preparedness Innovations

    collaborator OTHER

  • Valneva Austria GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-02
Primary Completion
2026-10-31
Completion
2027-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07254702 on ClinicalTrials.gov